Rochester Clinical Research is now enrolling adults who recently quit smoking for a study testing a once-weekly investigational medication that may help them stay smoke-free and avoid starting cigarettes again.
Rochester Clinical Research is now enrolling adults who recently quit smoking for a study testing a once-weekly investigational medication that may help them stay smoke-free and avoid starting cigarettes again.
Researchers are looking to learn if the investigational medicine may help reduce cravings, support staying smoke-free, and lower the chance of starting cigarettes again.
You may qualify if you:
Adults 18 and older with obstructive sleep apnea (OSA) and overweight or obesity may qualify for a clinical study evaluating […]
Rochester Clinical Research is seeking adults to participate in a research study evaluating an investigational medication for nerve pain caused […]
Adults 65 years and older may qualify for a study evaluating an investigational vaccine designed to help prevent C. difficile […]
Rochester Clinical Research is enrolling healthy adults ages 50–64 for a COVID-19 vaccine research study (non-mRNA). This study is enrolling […]
Rochester Clinical Research is currently enrolling adults for a research study evaluating a once-weekly injection for people with knee pain […]
Adults 18 to 80 years of age may qualify for a study evaluating an investigational treatment for irritable bowel syndrome […]